1 documents found
Head: Скрипник Ігор Миколайович. A randomized double-blind study, controlled active drug, and open extension to determine the efficacy, safety, long-term use and tolerability TR05 at a dose of 3.2 g / d for the treatment of active ulcerative colitis.
Ukrainian medical stomatological Academy. № 0115U001866
1 documents found
Updated: 2026-03-20
